Blockchain Registration Transaction Record
Telomir Pharmaceuticals Inc. Making Strides in Age Reversal Research with Telomir-1
Telomir Pharmaceuticals Inc. (NASDAQ: TELO) is gaining attention for its promising age reversal drug compound, Telomir-1, which has shown positive outcomes in a study with senior dogs. CEO Erez Aminov is dedicated to advancing the research necessary to bring this treatment to humans and pets.
This news matters because Telomir-1's potential to reverse age-related conditions could have a significant impact on human and pet health. With positive preclinical trials and encouraging results from a study with senior dogs, the company is one to watch in the ongoing pursuit of age reversal solutions.
Blockchain | Details |
---|---|
Contract Address | 0x0553B273B8eBf464Bd2a37C259F0eEBb3d70Fd71 |
Transaction ID | 0xa29fd8e2b8dc684be48ca35db9762c2b605463902cd6116345a89fe1d9e8c0c3 |
Account | 0xdBdE7c76e403a5923F3dD4F050Dbbf5c2077BB20 |
Chain | polygon-main |
NewsRamp Digital Fingerprint | fileFBdO-8a469ee152f000325e9b5171d3b422d3 |